Every round on record, with the sources behind each and the investors on them.
A provider of a biomarker strategy platform focused on neurodegenerative diseases and other proteopathies
seragy.comLinkedInHanover, GermanyOther
12 sources · checked 1 time, last 2h ago
Developing: it holds up against its sources so far, and firms up as more reporting lands.
The financing combines debt financing, equity capital, and public funding; The Michael J. Fox Foundation support is separately described as a grant.; not on the page it cites, so not applied: date
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Funding round | $13.4M €12M | 2026-10-14 | not stated | 10 outlets. #34 in Trending |
12 sources · checked 1 time, last 2h ago [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 4 of 12 sources The financing combines debt financing, equity capital, and public funding; The Michael J. Fox Foundation support is separately described as a grant.; not on the page it cites, so not applied: date | ||||